Correlation Between INC Research and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both INC Research and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INC Research and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INC Research Holdings and ANI Pharmaceuticals, you can compare the effects of market volatilities on INC Research and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INC Research with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of INC Research and ANI Pharmaceuticals.
Diversification Opportunities for INC Research and ANI Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between INC and ANI is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding INC Research Holdings and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and INC Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INC Research Holdings are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of INC Research i.e., INC Research and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between INC Research and ANI Pharmaceuticals
Given the investment horizon of 90 days INC Research Holdings is expected to under-perform the ANI Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, INC Research Holdings is 1.11 times less risky than ANI Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The ANI Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 5,550 in ANI Pharmaceuticals on December 26, 2024 and sell it today you would earn a total of 1,167 from holding ANI Pharmaceuticals or generate 21.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
INC Research Holdings vs. ANI Pharmaceuticals
Performance |
Timeline |
INC Research Holdings |
ANI Pharmaceuticals |
INC Research and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with INC Research and ANI Pharmaceuticals
The main advantage of trading using opposite INC Research and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INC Research position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.INC Research vs. AYR Strategies Class | INC Research vs. Verano Holdings Corp | INC Research vs. TILT Holdings | INC Research vs. Lowell Farms |
ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |